Cannabis use is associated with prevalent coronary artery disease

Travis M Skipina1, Nikhil Patel1, Bharathi Upadhya2

  • 1Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, NC, USA.

Insights

Cannabis use is linked to a higher likelihood of prevalent coronary artery disease (CAD). This study suggests potential cardiovascular risks associated with cannabis consumption, warranting further investigation.

Area of Science:

  • Cardiology
  • Public Health
  • Cannabis Research

Background:

  • Cannabis use is linked to acute coronary syndrome, but its association with prevalent coronary artery disease (CAD) is not well-established.
  • Observational studies suggest a potential cardiovascular risk, necessitating further research into cannabis's impact on existing CAD.

Purpose of the Study:

  • To investigate the association between cannabis use and prevalent coronary artery disease (CAD).
  • To hypothesize that cannabis use is associated with an increased likelihood of prevalent CAD.

Main Methods:

  • Analysis of 12,543 participants from The National Health and Nutrition Examination Survey (NHANES).
  • Self-reported cannabis use and physician-diagnosed prevalent CAD.
  • Multivariable logistic regression was used to test the association between cannabis use and CAD.

Main Results:

  • 53.1% of participants reported ever using cannabis; 1.1% had prevalent CAD.
  • Ever cannabis users showed a 90% increased odds of CAD (OR: 1.90, p=0.003).
  • Current and heavy cannabis users also demonstrated significantly increased odds of prevalent CAD.

Conclusions:

  • Cannabis use is significantly associated with prevalent coronary artery disease (CAD).
  • Findings highlight potential cardiovascular risks of cannabis use, especially as its acceptance grows globally.
  • Further research is needed to fully understand the cardiovascular implications of cannabis consumption.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
86
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
48
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
60
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
48
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
379
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
357